Emerging non-D2 receptor-based therapies for schizophrenia: a focus on muscarinic and glutamatergic pathways - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Innovative Therapies for Schizophrenia Beyond D2 Receptor Antagonism: Emphasizing Muscarinic and Glutamatergic Mechanisms

  • By

  • Yunxiang Wang

  • Jiajia Wang

  • Xiao Zhang

  • Xudong Liu

  • July 10, 2026

Share

Original Source(s)

Related Content